CMS, the Department of Labor, and the Department of Treasury issued joint guidance this week that is intended to ensure that Americans with private health insurance have coverage for COVID-19 diagnostic testing and related services at no cost. Specifically, coverage is required for both diagnostic testing and antibody testing and certain related items and services provided during a medical visit, with no cost sharing. This guidance will be helpful to employers that sponsor group health plans and insurers that provide health insurance coverage or provide third party administration services to group health plans. Please refer to this article by Sherry Porter for additional information.
By using this site, you agree to our updated Privacy Policy.
Necessary Cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytical Cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.
